Nxstage Medical (NXTM) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Equities rebound to close higher as surging Treasury yields recede
- onsemi cuts Synaptics deal price to $5.7B after rival bid
- Wells Fargo names 13 stocks as overweight tactical ideas
- Twilio, Vylor set to join S&P 500 as index reshuffles members
NxStage Reports Fourth Quarter and Full-Year 2016 Financial Results
February 28, 2017 8:05 AM ESTLAWRENCE, Mass., Feb. 28, 2017 /PRNewswire/ --
Highlights:
Full-Year Revenue Increases to $366 million, up 9% from 2015 Full-Year Home Revenue Increases to $209 million, up over 14% from 2015 Full-Year Operating Income from Products Business More than Doubles to $23 million Outlook for 2017 Includes Strong Revenue Growth and Total Company Profitability Company Continues to Target Introduction of Peritoneal Dialysis System at End of 2017